Astellas Pharma's treatment for hot flashes and sweats appro

A treatment option to reduce the number and intensity of hot flashes and night sweats associated with menopause has been approved by the European Commission (EC).

Related Keywords

Canada , Iceland , Norway , Liechtenstein , Rossella Nappi , European Union , University Of Pavia , European Union Eu Member States , Astellas Pharma Inc , Biopharma Development At Astellas , Research Center , San Matteo Foundation , European Medicines Agency , Committee For Medicinal Products Human Use , Astellas Pharma , Reproductive Medicine , Gynecological Endocrinology , Menopause Unit , Imatteo Foundation , Biopharma Development , Medicinal Products , Human Use , Clinical Endocrinology , Member States , Clinical Development , Ingredients , Atient Centricity , Pis Active Pharmaceutical Ingredients , Drug Delivery , Formulation , Hasei Ii , Menopause , Omen 039s Health , Astellas , European Commission ,